Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling evidence for the causal role of telomere shortening as a primary modifier of disease is that families with mutant telomerase genes display genetic anticipation39,83.”
From The telomere syndromes (2012) · cites this paper as [83]
In the citing paper
“Telomere length is influenced by many different factors, including age (13, 14) and the number of generations the mutation is transmitted (6, 15).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [15]
Citations
Cites
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationDyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Self-citationExtensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570
Function and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467
Structure and polymorphism of human telomere-associated DNA
Brown, W. R. A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J., & Dobson, M. J. (1990) · Cell · doi:10.1016/0092-8674(90)90293-n · Cited by 375
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 279
Self-citation
Cited by
Items 301–400 of 456
Oficialdegui, M. L. U., Navarro, S., Murillo, L., Rodríguez‐Vigil, C., Benítez‐Carabante, M. I., Goñi, C. B., Salinas, J. A., & de Heredia, C. D. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1182476 · Cited by 11
Hartwig, F. P., & Collares, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.003 · Cited by 11
La dyskératose congénitale : mise au point
Mialou, V., Leblanc, T. M., de Latour, R. P., Dalle, J., & Socié, G. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2012.12.003 · Cited by 13
Liu, L., Qin, J., Guo, T., Chen, P., Ouyang, R., Peng, H., & Luo, H. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1393 · Cited by 13
“, 2007), telomerase RNA component (TERC; OMIM 602322) (Vulliamy et al., 2004), poly(A)-specific ribonuclease (PARN; OMIM 604212) (Stuart et al.”
BackgroundShort Telomeres: Cause and Consequence in Liver Disease
Penrice, D. D., & Simonetto, D. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1713007 · Cited by 12
Other Well-Defined Immunodeficiencies
Yeganeh, M., Gambineri, E., Abolmaali, K., Tamizifar, B., & Español, T. (2008) · Springer eBooks · doi:10.1007/978-3-540-78936-9_9 · Cited by 10
Genetics of proliferative aging
Zucchero, T. M., & Ahmed, S. C. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.057 · Cited by 10
“However, bone marrow failure is not observed, perhaps because these patients rarely have children and haploinsufficiency for a telomerase component may be required for multiple generations to achieve telomeres short enough to cause severe replicative aging phenotypes (Vulliamy et al., 2004).”
POT of gold: modeling dyskeratosis congenita in the mouse: Figure 1.
Autexier, C. (2008) · Genes & Development · doi:10.1101/gad.1695808 · Cited by 10
Nelson, N. E., Feurstein, S. K., Niaz, A., Truong, J. Q., Holien, J. K., Lucas, S. E. M., Fairfax, K. A., Dickinson, J. L., & Bryan, T. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.021 · Cited by 11
Chen, J., Bryant, M., Dent, J. J., Sun, Y., Desierto, M. J., & Young, N. S. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.10.016 · Cited by 9
“…Hartmann et al., 2011), pulmonary fibrosis (Armanios et al., 2007; Cronkhite et al., 2008; Tsakiri et al., 2007; Tsang et al., 2012), and bone marrow (BM) failure (Armanios et al., 2005; Heiss et al., 1998; Ly et al., 2005; Vulliamy et al., 2004; Yamaguchi et al., 2003; Yamaguchi et al., 2005).”
BackgroundHou, H., & Cooper, J. P. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.002 · Cited by 11
Dyskeratosis Congenita and the Telomere Biology Disorders
Dodson, L. M., & Bertuch, A. A. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_6 · Cited by 8
Niaz, A., Truong, J. Q., Manoleras, A., Fox, L. C., Blombery, P. A., Vasireddy, R. S., Pickett, H. A., Curtin, J. A., Barbaro, P., Rodgers, J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007029 · Cited by 9
“TBDs also demonstrate marked anticipation (ie, an increase in severity of the phenotype and earlier onset of disease in subsequent generations), due to the inheritance of shorter telomeres with each generation.(30,31) Furthermore, in silico algorithms show very limited ability to discriminate between benign or deleter…”
Aref, S., El-Ghonemy, M. S., Abouzeid, T., El-Sabbagh, A. M., & ElBaiomy, M. A. (2014) · Medical Oncology · doi:10.1007/s12032-014-0158-6 · Cited by 8
“Loss of function mutations in telomerase complex genes reduces telomerase activity and can clinically manifest as bone marrow (BM) failure disease, which predispose to AML [5, 8, 12].”
BackgroundMolecular Diagnosis and Precision Therapeutic Approaches for Telomere Biology Disorders
Perona, R., Iarriccio, L., Pintado‐Berninches, L., Rodríguez-Centeno, J., Manguán-García, C., Garcia, E., López‐Ayllón, B. D., & Sastre, L. (2016) · InTech eBooks · doi:10.5772/65353 · Cited by 12
Wang, J., Peng, X., Chen, C., Ning, X., Peng, S., Li, T., Liu, S., Hong, B., Zhou, J., Ma, K., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00358 · Cited by 8
“Recently, GA has been reported in hereditary cancer syndromes including Lynch syndrome, Li-Fraumeni syndrome, dyskeratosis congenital and hereditary breast cancer, and was associated with genomic instability caused by shortening of telomere length in the next generations (Vulliamy et al., 2004; Tabori et al., 2007; Ma…”
BackgroundHe, C., Jing, S., Dai, C., Tu, C., Tan, Z., Du, J., Lu, G., Lin, G., & Zeng, S. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.709 · Cited by 7
“The change in age‐adjusted telomere length measurement between parent‐child combinations (ΔTELchild − ΔTELparent) in 56 normal families and the DC family.”
BackgroundInfluentialNouvelles formes de dyskératoses congénitales
Touzot, F., Guen, T. L., de Villartay, J., & Revy, P. (2012) · médecine/sciences · doi:10.1051/medsci/2012286015 · Cited by 10
Warner, H. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0892-6_15 · Cited by 7
Scahill, C. M., Digby, Z., Sealy, I. M., White, R. J., Wali, N., Collins, J. E., Stemple, D. L., & Busch‐Nentwich, E. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12530.2 · Cited by 7
The molecular basis of congenital thrombocytopenias: Insights into megakaryopoiesis
Geddis, A. E. (2005) · Hematology · doi:10.1080/10245330512331390401 · Cited by 12
“The molecular basis of congenital thrombocytopenias: Insights into megakaryopoiesis”
BackgroundAltered expression of telomere‐associated genes in leukocytes among BRCA1 and BRCA2 carriers
Tanaka, H., Phipps, E. A., Wei, T., Wu, X., Goswami, C. P., Liu, Y., Sledge, G. W., Mina, L. A., & Herbert, B. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22773 · Cited by 9
“All rights reserved 5 sometimes severity of disease in successive generations, has been attributed to telomere shortening in familial cancer syndromes such as Li-Fraumeni and dyskeratosis congenita [23,24].”
Gutierrez‐Rodrigues, F., Masri, N., Chouery, É., Diamond, C. E., Jalkh, N., Vicente, A., Kajigaya, S., Abillama, F. F., Bejjani, N. A., Serhal, W., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02076-8 · Cited by 8
“1 3 consistent with previous reports in which disease anticipation was observed in few individuals from the same family and onset of disease was two decades earlier in the proband and siblings compared to their mother (Vulliamy et al. 2004; Armanios et al. 2005; Kannengiesser et al. 2015).”
BackgroundMethodDyskeratosis congenita: a disorder of telomerase deficiency and its relationship to other diseases
Marrone, A., & Dokal, I. S. (2006) · Expert Review of Dermatology · doi:10.1586/17469872.1.3.463 · Cited by 7
Self-citationTelomeropathies in Interstitial Lung Disease and Lung Transplant Recipients
Southern, B. D., & Gadre, S. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051496 · Cited by 11
“Genetic anticipation can occur in TBD with individuals who carry autosomal dominant variants and pass the mutation, along with shortened telomeres, to their children [38].”
Un Nobel centenaire célèbre télomères et télomérase
Londoño‐Vallejo, A. (2009) · médecine/sciences · doi:10.1051/medsci/20092511973 · Cited by 8
Genetics of syndromic and non‐syndromic hereditary nail disorders
Bergqvist, C., Ramia, P., Abbas, O., & Kurban, M. (2017) · Clinical Genetics · doi:10.1111/cge.12852 · Cited by 5
Dokal, I. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00011-x · Cited by 6
Self-citationDyskeratosis congenita: Its connections with oral and maxillofacial surgery
Sabesan, T., Baheerathan, N. N., & Ilankovan, V. (2005) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2005.06.010 · Cited by 6
The genetic basis of natural variation in C. elegans telomere lengthPreprint
Cook, D. C., Zdraljevic, S., Tanny, R. E., Seo, B., Riccardi, D., Noble, L. M., Rockman, M. V., Alkema, M. J., Braendle, C., Kammenga, J. E., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/051276 · Cited by 7
“However, differences in telomere length caused by mutations in genes that encode telomere-associated proteins often do not have observable telomere defects for a number of generations (Vulliamy et al. 2004; Armanios et al. 2005; Marrone et al. 2005).”
BackgroundTelomere Dynamics in Human Health and Disease
Baird, D. M. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041701 · Cited by 7
“Whilst TBDs are caused by defined genetic variants, they can also display disease anticipation whereby the severity of the disease increases, and age of onset decreases, between generations (Vulliamy et al. 2004).”
Gong, Y., Wang, Y., Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Hooten, N. N., Croteau, D. L., Temre, M. K., Molnar, A. E., Bodogai, M., Zou, A., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112661 · Cited by 5
“Telomere shortening is a prominent hallmark of aging, intricately linked with age-related diseases and TBDs. 12,13,15,16,18 In clinical research, telomere length is predominantly measured using peripheral blood mononuclear cells (PBMCs).”
Dyskeratosis congenita: ein Literaturüberblick
Alsabbagh, M. M. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14268_g · Cited by 8
Roake, C. M., Juntilla, M. M., Agarwal, R., Artandi, S. E., & Kuo, C. S. (2021) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2021.200517 · Cited by 8
“Germline inheritance may also show disease anticipation, with relatives suffering from only cytopenias or pulmonary fibrosis while later generations are more affected by the inheritance of shorter telomeres [3].”
BackgroundTannouri, R. E., Albuisson, É., Jonveaux, P., & Luporsi, É. (2017) · Familial Cancer · doi:10.1007/s10689-017-9999-4 · Cited by 6
“Telomere shortening has been described as a mechanism of anticipation in genetic disorders such as dyskeratosis congenital [12], Li-Fraumeni Syndrome [7] as well as familial breast cancer associated with BRCA1 and BRCA2 inherited mutations [8].”
BackgroundAgrusa, J. E., Bertuch, A. A., Dinardo, C. D., Plon, S. E., & Eckstein, O. S. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27779 · Cited by 5
Roberts, A. R., Huang, E., Jones, L., Daxinger, L., Chong, S., & Whitelaw, E. (2013) · Chromosoma · doi:10.1007/s00412-013-0427-8 · Cited by 5
“Disease anticipation is observed in affected families and is associated with the inheritance of progressively shorter telomeres (Vulliamy et al. 2004; Armanios et al. 2005).”
BackgroundShortened Telomeres: A Driving Force Behind Leukemia?
Pepper, C. J., & Baird, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.135 · Cited by 6
“These mutations result in often extreme telomere shortening in this condition [27].”
BackgroundTelomerase dysfunction and dyskeratosis congenita
Walne, A. J., & Dokal, I. S. (2004) · Cytotechnology · doi:10.1007/s10616-004-5121-5 · Cited by 5
“AA Vulliamy et al. (2002) AA Fogarty et al. (2003) Controls Wilson et al. (2003) 72 C fi G Pseudoknot CAA Vulliamy et al. (2002) 96,7 DCT Pseudoknot DC Vulliamy et al. (2004) 107,8 GC fi AG Pseudoknot DC Vulliamy et al. (2001b) 110–3 DGACT Pseudoknot CAA Vulliamy et al. (2002) 116 C fi T Pseudoknot AA Fogarty et al. (…”
BackgroundInfluentialSelf-citationNakamura, A., Suda, T., Honma, T., Takahashi, T., Igarashi, M., Waguri, N., Kawai, H., Mita, Y., & Aoyagi, Y. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042256.89282.c4 · Cited by 5
“and knockdown and mutation of hTRcause reduction of telomerase activity (14) and an inherited disease (15), respectively.”
BackgroundThe Bur1 cyclin‐dependent kinase regulates telomere length in Saccharomyces cerevisiae
Connelly, C. J., Vidal-Cardenas, S. L., Goldsmith, S., & Greider, C. W. (2021) · Yeast · doi:10.1002/yea.3680 · Cited by 5
“First, the components of telomerase, required for telomere elongation, are limiting in cells (Armanios et al., 2005; Mozdy & Cech, 2006; Vulliamy et al., 2004).”
BackgroundBarabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
“These include diseases related to mutations in the DNA damage response (DDR) and in the DNA repair pathways, such as Fanconi anemia [38] and ERCC6L2-associated bone marrow failure syndrome [39]; telomere maintenance, such as in dyskeratosis congenita or telomeropathies [40,41]; TP53 loss-of-function in Li-Fraumeni syn…”
BackgroundTelomere length as a biomarker of aging and diseases
Guzonjić, A., Sopić, M., Ostanek, B., & Kotur‐Stevuljević, J. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-36376 · Cited by 5
Dynamics and plasticity of chromosome ends: consequences in human pathologies
Schluth‐Bolard, C., Ottaviani, A., Bah, A., Boussouar, A., Gilson, É., & Magdinier, F. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44767 · Cited by 5
“The genetic alteration underlying the autosomal recessive form f DKC is currently unknown (Mitchell et al., 1999; Vulliamy et al., 2001; Vulliamy et al., 2004).”
BackgroundTomlinson, C. G., Cohen, S. B., & Bryan, T. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00017-6 · Cited by 4
Takaoka, K., Koya, J., Yoshimi, A., Toya, T., Kobayashi, T., Nannya, Y., Nakazaki, K., Arai, S., Ueno, H., Usuki, K., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1734595 · Cited by 4
“Besides RUNX1 mutation, several gene alterations such as GATA binding protein 2 (GATA2) [2], CCAAT enhancer binding protein alpha (CEBPA) [26], telomerase RNA component (TERC) [10,27], death inducer-obliterator 1 (DIDO1) [28], DEAD-box helicase 41 (DDX41) [29], ETS variant 6 (ETV6) [30], signal recognition particle 72…”
BackgroundBenson, K. F., & Horwitz, M. S. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.11.002 · Cited by 5
The Genetics of Interstitial Lung Diseases
Borie, R., Guen, P. L., Ghanem, M., Taillé, C., Mathai, S. K., Dieudé, P., Kannengiesser, C., & Crestani, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11453-9 · Cited by 4
Zhu, D., Patel, N., Pishko, A. M., Weinberg, E. M., Takako, T. I., Kallish, S., Johnson, F. B., Babushok, D. V., & Courtwright, A. (2025) · ERJ Open Research · doi:10.1183/23120541.00875-2024 · Cited by 4
Interstitial and Restrictive Pulmonary Disorders
Lawson, W. E., & Loyd, J. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00065-3 · Cited by 3
Fernández-Varas, B., Manguán-García, C., Rodríguez-Centeno, J., Mendoza-Lupiáñez, L., Calatayud, J., Perona, R., Martín‐Martinez, M., Gutiérrez‐Rodríguez, M., Benitéz‐Buelga, C., & Sastre, L. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae015 · Cited by 5
“Most variants from patients diagnosed of dyskeratosis congenita showed decreased in vitro telomerase activity ( TERT p.Phe159CysfsTer32, p.Arg698Trp; TERC n.96_97delCT) [8, 41, 53], with the exception of the variant p.Thr1101Met, that is described in this article.”
BackgroundGenetic Interstitial Lung Disease
Garcia, C. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48024-6.00001-x · Cited by 4
Inherited Risk for Childhood Leukemia
Vagher, J., Maese, L. D., Gammon, A., Kohlmann, W. K., & Schiffman, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_11 · Cited by 3
Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
Filipiuk, A., Kozakiewicz, A., Kośmider, K., Lejman, M., & Zawitkowska, J. (2022) · Cancers · doi:10.3390/cancers14153569 · Cited by 3
“Disease anticipation is associated with the progressive shortening of telomeres [45].”
BackgroundDyskeratosis Congenita Links Telomere Attrition to Age-Related Systemic Energetics
James, E. N., Sági‐Kiss, V., Bennett, M. H., Mycielska, M. E., Karen‐Ng, L. P., Roberts, T., Matta, S., Dokal, I. S., Bundy, J. G., & Parkinson, E. K. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad018 · Cited by 5
“In addition, as with telomerase-deficient mice (13), LAATL decreases with each generation (44).”
BackgroundSelf-citationMaiti, S. N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3684-7_5 · Cited by 3
Anemias raras y fallos medulares hereditarios
Corrons, J. V., Pereira, M. D. M. M., Trujillo‐Quintero, J. P., Surrallés, J., & Sevilla, J. (2018) · Arbor · doi:10.3989/arbor.2018.789n3005 · Cited by 4
Vagher, J., Gammon, A., Kohlmann, W. K., & Jeter, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837059 · Cited by 4
“In individuals who have autosomal dominant disease, genetic anticipation affecting disease severity in successive generations has been reported (13, 14).”
BackgroundSáez‐de‐Ocariz, M., Orozco‐Covarrubias, L., Durán‐McKinster, C., & Ruiz‐Maldonado, R. (2008) · Springer eBooks · doi:10.1007/978-3-211-69500-5_44 · Cited by 3
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer
Coukos, A., Daccord, C., Lazor, R., Blum, S., Naveiras, O., Unger, S., Vionnet, J., Gaide, O., Koutsokera, A., Moschouri, E., et al. (2022) · JMIG · doi:10.53738/revmed.2022.18.793.1606 · Cited by 3
Carlier, F. M., Planté-Bordeneuve, T., Froidure, A., Graux, C., van Dievoet, M., van Moorsel, C. H. M., & Hoffman, T. W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718107 · Cited by 7
Telomere Instability in Lynch Syndrome Families Leads to Some Shorter Telomeres in MSH2+/- Carriers
Garrido-Navas, M. C., Tippins, F., Barwell, J., Hoffman, J., Codd, V., & Royle, N. J. (2020) · Life · doi:10.3390/life10110265 · Cited by 3
“investigate inter-generational differences in telom re length i LS and control famili s, telome easurements we compared after adjusting for age (ΔTel) [17].”
BackgroundMethodInfluentialGenetic Counseling and Family Screening Recommendations in Patients with Telomere Biology Disorders
Ongie, L. J., Raj, H. A., & Stevens, K. B. (2023) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00713-8 · Cited by 2
Carlund, O., Norberg, A., Osterman, P., Andersson, I., Eriksson, A., Degerman, S., & Hultdin, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-12566-7 · Cited by 3
“of the variant with disease in the family 9,13,14 .”
Genetic aspects of telomere biology disorders
de Tocqueville, S., Morel, H., Ba, I., Revy, P., & Kannengiesser, C. (2025) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.03.011 · Cited by 2
Cancer & inherited bone marrow failure states
Nichols, K. E., & Bessler, M. (2009) · Blood · doi:10.1182/blood-2009-04-213116 · Cited by 2
The Stem Cell Hypothesis of Aging
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.108 · Cited by 2
Aplasies médullaires constitutionnelles
Mialou, V., Leblanc, T. M., de Latour, R. P., Dalles, J.-H., & Socié, G. (2011) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(11)47150-8 · Cited by 2
Critical role of the POT1 OB domain in maintaining genomic stability
Pandita, T. K. (2016) · Oncogene · doi:10.1038/onc.2016.365 · Cited by 3
Gutierrez, L. G., & Ju, Z. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_8 · Cited by 7
Telomerase Mutations and Premature Ageing in Humans
Du, H., Bessler, M., & Mason, P. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_5 · Cited by 2
Self-citationTelomere Binding Proteins and Disease
Blasco, M. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_12 · Cited by 2
Genetics of Pulmonary Fibrosis
Adams, T. N., & Garcia, C. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_8 · Cited by 3
Babushok, D. V., Hsu, A. P., & Dokal, I. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00016-8 · Cited by 2
Self-citationOther Well-Defined Immunodeficiencies
Gennery, A. R., Maródi, L., Ziegler, J. B., Español, T., & Grimbacher, B. (2016) · Springer eBooks · doi:10.1007/978-3-662-52909-6_9 · Cited by 2
Irvine, A. D., & Mellerio, J. E. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0078 · Cited by 2
Long-Telomeropathy is Associated with Tumor Predisposition SyndromePreprint
Allaire, P., Mayer, J. G., Moat, L. F., Gabor, R., Shay, J. W., He, J., Zeng, C., Bastarache, L. A., & Hebbring, S. J. (2024) · SSRN Electronic Journal · doi:10.1101/2024.11.26.24318007 · Cited by 2
Pseudo‐anticipation in Creutzfeldt–Jakob disease is due to a rhomboid‐shaped artifact
Cohen, O. S., Kahana, E., Korczyn, A. D., Ziv‐Baran, T., Nitsan, Z., Appel, S. A., Rosenmann, H., & Chapman, J. (2019) · European Journal of Neurology · doi:10.1111/ene.14138 · Cited by 1
“3) In the E200K mutation there are no known trinucleotide repeats and no other alternative relevant molecular mechanisms (such as those reported in cancer including other types of repeated sequences, the presence of a modifier gene [16] and telomere shortening [17]) have been described in the PRNP gene.”
BackgroundA case report of dyskeratosis congenita caused by a novel TERC mutation
Liang, W., Ye, L., & Zhang, F. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05424-x · Cited by 1
“Disease anticipation is associated with progressive telomere shortening [6].”
BackgroundGenetic Familial Interstitial Lung Disease
Fernandez, R. J., & Kropski, J. A. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.07.008 · Cited by 1
DeCleene, N. F., Nguyen, D. T., Kirk, S. E., Helber, H. L., Sasa, G., & Bertuch, A. A. (2025) · British Journal of Haematology · doi:10.1111/bjh.70155 · Cited by 1
“29,30 Consequently, young individuals with de novo PVs, such as in the TERT gene, may not exhibit VL TLs, and clinical manifestations may emerge only later in adulthood.”
Schratz, K. E., & Armanios, M. Y. (2026) · NEJM Evidence · doi:10.1056/evidra2600012 · Cited by 2
How telomere attrition protects against cancer
Stuart, A., Zhang, B., Hockemeyer, D. F., & de Lange, T. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-01001-w · Cited by 1
“This scenario is in contrast to the generational anticipation observed in short-telomere syndromes, in which the telomeres progressively erode over generations 139 (but see ref.”
Telomere length of both parents contributes to heritable POT1 cancer-predisposition syndrome
Martin, A., Lu, R., Blake, A., Nichols, K. E., Sanchez, S. E., Artandi, S. E., Savage, S. A., Sharma, R., & Hockemeyer, D. F. (2026) · Nature Communications · doi:10.1038/s41467-026-77414-2 · Cited by 1
“Consistent with this mechanism, decreased generational telomere length following both maternal and paternal inheritance of short telomeres has been documented 27,28 .”
Slijepčević, P. (2007) · Acta Medica Academica · Cited by 1
Telomere length as a biomarker for cerebrovascular diseases: current evidence
Agostini, L. D. C., & da Silva, G. N. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10077-8 · Cited by 1
“Dominant autosomal variants affecting the TERC gene or mutations in the dyskerin (DKC1) gene, associated with the X-linked form of the disease, result in instability of the TERC protein [63].”
Genetic Determinants of Interstitial Lung Diseases
Mathai, S. K., Schwartz, D. A., & Borie, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00015-x · Cited by 1
Genetics of Idiopathic Pulmonary Fibrosis
Mathai, S. K., & Schwartz, D. A. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_6 · Cited by 1
Cancer-Prone Inherited Bone Marrow Failure, Myelodysplastic, and Acute Myeloid Leukemia Syndromes
Savage, S. A., McReynolds, L. J., Niewisch, M. R., Altintas, B., Gianferante, D. M., & Alter, B. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_10 · Cited by 1
Inherited Bone Failure Syndromes, Focus on the Haematological Manifestations: A Review
Foglesong, J. S., Bannon, S. A., & Dinardo, C. D. (2017) · European Medical Journal · doi:10.33590/emj/10310433 · Cited by 1
Relationship between DNA damage response and telomere maintenance
Ojani, M. (2012) · Brunel University Research Archive (BURA) (Brunel University London) · Cited by 5
Congenital bone marrow failure involving the red blood cells
Gordon‐Smith, E. C. (2005) · Hematology · doi:10.1080/10245330512331389962 · Cited by 1
Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
LLeonart, M. E., Carnero, A., Paciucci, R., Wang, Z., & Shomron, N. (2011) · Journal of Aging Research · doi:10.4061/2011/692301 · Cited by 3
Télomères, maladies et vieillissement
Kahn, A. (2005) · médecine/sciences · doi:10.1051/medsci/2005215451 · Cited by 1
“Aussi bien dans la dyskeratosis congenita que dans les observations récemment publiées de mutations de TERT associées à des anémies aplastiques, une corrélation existe entre les symptômes et le raccourcissement des télomères [6].”
BackgroundFilipovich, A. H., Bleesing, J., & Goldman, F. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.10.003 · Cited by 1
Establishment and validation of a telomere length assay
Jodczyk, S. (2011) · Otago University Research Archive (University of Otago) · Cited by 3
Telomere length as a putative biomarker of health and disease
Appleby, S. (2016) · Otago University Research Archive (University of Otago) · Cited by 1
The Immunologic Complications and Genetic Origins of Telomere Disorders
Revy, P., & Touzot, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.18007-5 · Cited by 2
Stindl, R. (2016) · doi:10.15200/winn.147180.05742 · Cited by 1
“The proposed causal mechanism, which is telomere-driven aging of the germline (Stindl 2014), will result in disease anticipation in subsequent generations (Vulliamy et al. 2004) and probably the extinction of the Tasmanian devil.”
BackgroundBiochemical and structural analysis of shelterin subcomplexes
Inian, O. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/75683 · Cited by 1
Metadata
- Authors
- Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I.
- Affiliations
- Hammersmith Hospital (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Mason, Philip J
- Venue
- Nature Genetics
- Published
- 2004-04-18
- Volume
- 36
- Issue
- 5
- Pages
- 447-449
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2025843494
- Cited by
- 461
- References
- 15
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 16 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 15 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- dyskeratosis congenita, telomere shortening, TERC mutations, telomerase RNA, telomerase, bone marrow failure, autosomal dominant inheritance
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Family, Female, Genes, Dominant, Humans, Male, Middle Aged, Mutation, Pedigree, RNA, Telomere, Sequence Deletion, Telomerase, Dyskeratosis Congenita
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.